Contact
    Start Publications Can oxysterols work in anti-glioblastoma therapy? Model studies ...
    ←  Publication Finder
    KSV NIMA

    Can oxysterols work in anti-glioblastoma therapy? Model studies complemented with biological experiments

    Year: 2021

    Journal: Biochim. Biophys. Acta-Biomembr., Volume 1863, DEC 1

    Authors: Wnetrzak, Anita; Kubisiak, Agata; Filiczkowska, Anna; Gonet-Surowka, Agnieszka; Chachaj-Brekiesz, Anna; Targosz-Korecka, Marta; Dynarowicz-Latka, Patrycja

    Organizations: Polish Ministry of Science and Higher Education subvention [N17/MNS/000019/2019]

    Keywords: Glioblastoma multiforme; Model membrane; Oxysterols; Anti-cancer activity; AFM; Langmuir monolayers

    Despite the progress made in recent years in the field of oncology, the results of glioblastoma treatment remain unsatisfactory. In this paper, cholesterol derivatives - oxysterols - have been investigated in the context of their anti-cancer activity. First, the influence of three oxysterols (7-K, 7 beta-OH and 25-OH), differing in their chemical structure, on the properties of a model membrane imitating glioblastoma multiforme (GBM) cells was investigated. For this purpose, the Langmuir monolayer technique was applied. The obtained results clearly show that oxysterols modify the structure of the membrane by its stiffening, with the 7-K effect being the most pronounced. Next, the influence of 7-K on the nanomechanical properties of glioblastoma cells (U-251 line) was verified with AFM. It has been shown that 7-K has a dose-dependent cytotoxic effect on glioblastoma cells leading to the induction of apoptosis as confirmed by viability tests. Interestingly, significant changes in membrane structure, characteristic for phospholipidosis, has also been observed. Based on our results we believe that oxystemlinduced apoptosis and phospholipidosis are related and may share common signaling pathways. Dysregulation of lipids in phospholipidosis inhibit cell proliferation and may play key roles in the induction of apoptosis by oxysterols. Moreover, anticancer activity of these compounds may be related to the immobilization of cancer cells as a result of stiffening effect caused by oxysterols. Therefore, we believe that oxysterols are good candidates as new therapeutic molecules as an alternative to the aggressive treatment of GBM currently in use.
    View publication